AI Verdict
JAZZ has stronger fundamentals based on our AI analysis.
JAZZ vs JAGX Fundamental Comparison
| Metric | JAZZ | JAGX |
|---|---|---|
| Revenue | $4.3B | $8.3M |
| Net Income | $-356.1M | $-30.4M |
| Net Margin | -8.3% | -367.0% |
| ROE | -8.2% | -696.8% |
| ROA | -3.1% | -61.4% |
| Current Ratio | 1.86x | 0.81x |
| Debt/Equity | 1.24x | 1.43x |
| EPS | $-5.84 | $-22.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
JAZZ vs JAGX: Frequently Asked Questions
Is JAZZ or JAGX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JAZZ has stronger fundamentals. JAZZ is rated SELL (78% confidence) while JAGX is rated STRONG SELL (92% confidence). This is not investment advice.
How does JAZZ compare to JAGX fundamentally?
Jazz Pharmaceuticals plc has ROE of -8.2% vs Jaguar Health, Inc.'s -696.8%. Net margins are -8.3% vs -367.0% respectively.
Which stock pays higher dividends, JAZZ or JAGX?
JAZZ has a dividend yield of N/A or no dividend while JAGX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in JAZZ or JAGX for long term?
For long-term investing, consider that JAZZ has SELL rating with 78% confidence, while JAGX has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about JAZZ vs JAGX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For JAZZ vs JAGX, the AI consensus favors JAZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.